Boston Family Office LLC Raises Stock Holdings in Xylem Inc. $XYL

Key Points

• Boston Family Office LLC increased its stake in Xylem Inc. by 10.6%, owning 86,887 shares worth approximately $10.38 million as of the end of the reporting period.
• Several analysts have upgraded their ratings for Xylem, with Stifel Nicolaus raising the target price from $162 to $175, reflecting a consensus rating of "Moderate Buy."
• Xylem recently announced a dividend of $0.40 per share, set to be paid on September 25, contributing to an annualized dividend yield of 1.1%.

Boston Family Office LLC grew its stake in Xylem Inc. (NYSE:XYL - Free Report) by 10.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 86,887 shares of the industrial products company's stock after acquiring an additional 8,308 shares during the quarter. Boston Family Office LLC's holdings in Xylem were worth $10,380,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Northern Trust Corp grew its holdings in shares of Xylem by 42.0% during the 4th quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock worth $379,204,000 after purchasing an additional 966,399 shares during the period. Nuveen LLC purchased a new position in shares of Xylem during the 1st quarter worth $99,726,000. OVERSEA CHINESE BANKING Corp Ltd grew its holdings in shares of Xylem by 390.5% during the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock worth $122,009,000 after purchasing an additional 813,100 shares during the period. Vaughan Nelson Investment Management L.P. purchased a new position in shares of Xylem during the 1st quarter worth $89,828,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Xylem during the 4th quarter worth $83,139,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Price Performance

XYL stock traded up $0.87 on Tuesday, reaching $141.72. 1,177,045 shares of the company's stock were exchanged, compared to its average volume of 1,151,543. The stock has a fifty day moving average of $133.08 and a 200-day moving average of $126.01. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.33. The firm has a market cap of $34.50 billion, a PE ratio of 30.75, a P/E/G ratio of 2.44 and a beta of 1.11. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same quarter in the prior year, the company posted $1.09 earnings per share. Xylem's quarterly revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's payout ratio is presently 41.56%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on XYL. UBS Group raised their target price on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Raymond James Financial raised Xylem to a "hold" rating in a research report on Thursday, May 15th. Stifel Nicolaus lifted their price target on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Royal Bank Of Canada lifted their price target on Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Finally, Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Six research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Xylem currently has an average rating of "Moderate Buy" and a consensus price target of $151.57.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.